{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:57:49Z","timestamp":1776733069742,"version":"3.51.2"},"reference-count":17,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.aohep.2019.11.006","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T05:48:10Z","timestamp":1575524890000},"page":"222-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV"],"prefix":"10.1016","volume":"19","author":[{"given":"Valentina","family":"Cacciato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Casagrande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Bodini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuele","family":"Furnari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Marabotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo G.","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2019.11.006_bib0090","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep4.1248","article-title":"Autoimmune hepatitis during ledipasvir\/sofosbuvir treatment of hepatitis C: a case report","volume":"2","author":"Covini","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2019.11.006_bib0095","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2169\/internalmedicine.0613-17","article-title":"Development of autoimmune hepatitis during direct-acting antiviral therapy for chronic hepatitis C virus infection","volume":"57","author":"Matsumoto","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.aohep.2019.11.006_bib0100","doi-asserted-by":"crossref","first-page":"8916","DOI":"10.3748\/wjg.v19.i47.8916","article-title":"Immunological alterations in hepatitis C virus infection","volume":"19","author":"Calvaruso","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2019.11.006_bib0105","first-page":"215","article-title":"Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals","volume":"129","author":"Fleischer-St\u0119pniewska","year":"2019","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.aohep.2019.11.006_bib0110","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2893.2004.00489.x","article-title":"Does an \u2018autoimmune\u2019 profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey","volume":"11","author":"Stroffolini","year":"2004","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.aohep.2019.11.006_bib0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0168-8278(05)80281-8","article-title":"Non-organ specific autoantibodies associated with chronic C virus hepatitis","volume":"18","author":"Abuaf","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2019.11.006_bib0120","first-page":"613","article-title":"High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C","volume":"21","author":"Clifford","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.11.006_bib0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"issue":"Suppl. 1","key":"10.1016\/j.aohep.2019.11.006_bib0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0168-8278(99)80372-9","article-title":"Autoimmunity and extrahepatic manifestations in hepatitis C virus infection","volume":"31","author":"Manns","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2019.11.006_bib0135","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for te diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2019.11.006_bib0140","doi-asserted-by":"crossref","first-page":"e13056","DOI":"10.1111\/eci.13056","article-title":"Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals","volume":"49","author":"Giannini","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.aohep.2019.11.006_bib0145","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2036.2009.04201.x","article-title":"Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients","volume":"31","author":"Giannini","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2019.11.006_bib0150","doi-asserted-by":"crossref","first-page":"11631","DOI":"10.18632\/oncotarget.24391","article-title":"Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis","volume":"9","author":"Kanda","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.aohep.2019.11.006_bib0155","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.5604\/01.3001.0012.7208","article-title":"Improvement in Waldenstr\u00f6m's Macroglobulinemia after successful treatment of HCV with direct-acting antivirals","volume":"17","author":"Crespi","year":"2018","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2019.11.006_bib0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10620-018-5356-1","article-title":"Successful DAA treatment and global improvement in a cirrhotic patient with concomitant HCV infection and autoimmune hepatitis","volume":"64","author":"De Maria","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2019.11.006_bib0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000475752","article-title":"Successful treatment for chronic hepatitis C-autoimmune hepatitis overlap syndrome due to daclatasvir and asunaprevir","volume":"11","author":"Sugiura","year":"2017","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.aohep.2019.11.006_bib0170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/hep4.1388","article-title":"Direct-Acting Antiviral treatment of patients with hepatitis C resolves serologic and histopathologic features of autoimmune hepatitis","volume":"3","author":"Simoes","year":"2019","journal-title":"Hepatol Commun"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526811932277X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526811932277X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:40:03Z","timestamp":1761648003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526811932277X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S166526811932277X"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2019.11.006","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eradication of hepatitis C virus infection disclosing a previously hidden, underlying autoimmune hepatitis: Autoimmune hepatitis and HCV","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2019.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}